Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer Survival
  2. Roszik, Jason; Lee, J Jack; Wu, Yi-Hung; Liu,Xi; Kawakami, Masanori; Kurie, Jonathan M; Belouali, Anas; Boca, Simina M; Gupta, Samir; Beckman, Robert A; Madhavan, Subha; Dmitrovsky,Ethan
  3. Cancer Research Communications. 2022, Jul; 2(7): 590-601.
  1. 2.   Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes
  2. Shrimp, Jonathan; Garlick, Julie M.; Tezil, Tugsan; Sorum, Alexander W.; Worth, Andrew J.; Blair, Ian A.; Verdin, Eric; Snyder, Nathaniel W.; Meier, Jordan
  3. MOLECULAR PHARMACEUTICS. 2018, Mar; 15(3, Special Issue): 729-736.
  1. 3.   Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O-2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as Safe Anti-Inflammatory, Analgesic, Antipyretic, Antioxidant Prodrugs
  2. Chattopadhyay, M.; Velazquez, C. A.; Pruski, A.; Nia, K. V.; Abdellatif, K. R.; Keefer, L. K.; Kashfi, K.
  3. Journal of Pharmacology and Experimental Therapeutics. 2010, Nov; 335(2): 443-450.
  1. 4.   Second-generation aspirin and indomethacin prodrugs possessing an O-2-(Acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation, and nitric oxide release studies
  2. Velazquez, C. A.; Chen, Q. H.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Journal of Medicinal Chemistry. 2008 51(6): 1954-1961.
  1. 5.   O-2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies
  2. Velazquez, C. A.; Rao, P. N. P.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Bioorganic & Medicinal Chemistry. 2007, Jul; 15(14): 4767-4774.
  1. 6.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 7.   Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents
  2. Zhu, J. X.; Song, X. Q.; Lin, H. P.; Young, D. C.; Yan, S. Q.; Marquez, V. E.; Chen, C. S.
  3. Journal of the National Cancer Institute. 2002 94(23): 1745-1757.
  1. 8.   Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; Is chemoprevention against multidrug resistance possible?
  2. Ratnasinghe, D.; Daschner, P. J.; Anver, M. R.; Kasprzak, B. H.; Taylor, P. R.; Yeh, G. C.; Tangrea, J. A.
  3. Anticancer Research. 2001 21(3C): 2141-2147.
  1. 9.   Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey
  2. Ratnasinghe, D.; Tangrea, J.; Roth, M. J.; Dawsey, S.; Hu, N.; Anver, M.; Wang, Q. H.; Taylor, P. R.
  3. Anticancer Research. 1999 19(1A): 171-174.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel